Compare IESC & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IESC | SNN |
|---|---|---|
| Founded | 1997 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.3B |
| IPO Year | 1997 | 2002 |
| Metric | IESC | SNN |
|---|---|---|
| Price | $327.69 | $29.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $458.00 | $36.25 |
| AVG Volume (30 Days) | 171.8K | ★ 1.4M |
| Earning Date | 05-01-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 51.87 | N/A |
| EPS | ★ 17.52 | N/A |
| Revenue | ★ $3,371,468,000.00 | N/A |
| Revenue This Year | $22.20 | $8.58 |
| Revenue Next Year | $14.88 | $5.60 |
| P/E Ratio | ★ $39.10 | $64.97 |
| Revenue Growth | ★ 16.89 | N/A |
| 52 Week Low | $333.26 | $28.56 |
| 52 Week High | $816.51 | $38.79 |
| Indicator | IESC | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 23.82 | 45.05 |
| Support Level | N/A | $29.24 |
| Resistance Level | $496.74 | $31.18 |
| Average True Range (ATR) | 39.03 | 0.43 |
| MACD | -32.29 | -0.12 |
| Stochastic Oscillator | 0.59 | 51.78 |
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.